COMMUNITY - the COVID-19 Immunity Study

Abroad (travel likely)Recruiting

Conditions

COVID 19 · Respiratory Synctial Virus · Influenza Virus · SARS-CoV-2 Virus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Danderyd hospital, Stockholm, Sweden
Contact: Study coordinator (Nina Greilert, RN) · nina.greilert@ki.se · +46812355000
Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Contact: Study coordinator (Nina Greilert, RN) · nina.greilert@ki.se · +46812355000

Study leads

Charlotte Thålin, MD, PhD
Principal Investigator
Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

SARS-CoV-2 · Influenza, Human · Respiratory Syncytial Virus Infections

Abroad (travel likely)RecruitingPHASE1, PHASE2

Alcalá de Henares, Spain · Fuenlabrada, Spain

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Influenza · COVID-19

Abroad (travel likely)Recruiting

Bethesda, United States

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

COVID

Abroad (travel likely)Recruiting

San Francisco, United States

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

Coronavirus Infections

Abroad (travel likely)Recruiting

Nice, France